Kejia Wu

539 total citations
20 papers, 384 citations indexed

About

Kejia Wu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kejia Wu has authored 20 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kejia Wu's work include Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Kejia Wu is often cited by papers focused on Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Kejia Wu collaborates with scholars based in China, Ireland and United States. Kejia Wu's co-authors include Yuexiong Yi, Wanrong Wu, Yan Fang, Yanyan Liu, Wei Zhang, Wei Zhang, Yanyan Liu, Yurou Chen, Qiongying Lv and Wei Zhang and has published in prestigious journals such as Scientific Reports, Cell Reports and Oncotarget.

In The Last Decade

Kejia Wu

17 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kejia Wu China 12 233 160 45 44 37 20 384
Yixia Yang China 14 306 1.3× 166 1.0× 88 2.0× 62 1.4× 39 1.1× 34 633
Ci Zhao China 10 312 1.3× 286 1.8× 46 1.0× 41 0.9× 24 0.6× 12 427
Lu Wu China 12 181 0.8× 91 0.6× 67 1.5× 34 0.8× 29 0.8× 22 336
Boqun Xu China 14 319 1.4× 148 0.9× 50 1.1× 88 2.0× 11 0.3× 29 591
Yuefeng He China 12 208 0.9× 106 0.7× 26 0.6× 31 0.7× 31 0.8× 38 361
Kostiantyn Dreval United States 12 224 1.0× 114 0.7× 34 0.8× 21 0.5× 88 2.4× 25 371
Yiran Qiu United States 11 238 1.0× 130 0.8× 128 2.8× 75 1.7× 22 0.6× 34 437
Dhiral Phadke United States 10 295 1.3× 78 0.5× 111 2.5× 72 1.6× 16 0.4× 25 473
Leilei Tang China 12 161 0.7× 86 0.5× 26 0.6× 42 1.0× 15 0.4× 20 336

Countries citing papers authored by Kejia Wu

Since Specialization
Citations

This map shows the geographic impact of Kejia Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejia Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejia Wu more than expected).

Fields of papers citing papers by Kejia Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejia Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejia Wu. The network helps show where Kejia Wu may publish in the future.

Co-authorship network of co-authors of Kejia Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Kejia Wu. A scholar is included among the top collaborators of Kejia Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kejia Wu. Kejia Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Rong, et al.. (2025). Association of male sleep quality with semen parameters and pregnancy outcomes in infertile couple. Basic and Clinical Andrology. 35(1). 37–37.
2.
Guan, Hongwei, et al.. (2025). Advances in exosomal non‑coding RNAs in cervical cancer (Review). Molecular and Clinical Oncology. 23(6). 1–9.
3.
Li, Changying, Lingwen Kong, Yue Shao, et al.. (2024). Integrated analyses of Mendelian randomization, eQTL, and single-cell transcriptome identify CCN3 as a potential biomarker in aortic dissection. Scientific Reports. 14(1). 32062–32062.
4.
Wu, Kejia, et al.. (2023). Pyroptosis in neurodegenerative diseases: from bench to bedside. Cell Biology and Toxicology. 39(6). 2467–2499. 16 indexed citations
5.
Gui, Siyu, et al.. (2022). Association between per- and polyfluoroalkyl substances exposure and risk of diabetes: a systematic review and meta-analysis. Journal of Exposure Science & Environmental Epidemiology. 33(1). 40–55. 43 indexed citations
6.
Li, Niannian, Yuenan Liu, Kejia Wu, et al.. (2022). Comprehensive Analysis of N6-Methyladenosine Regulators in the Subcluster Classification and Drug Candidates Prediction of Severe Obstructive Sleep Apnea. Frontiers in Genetics. 13. 862972–862972. 2 indexed citations
7.
Fan, Guanlan, Fan Wang, Yurou Chen, et al.. (2022). The deubiquitinase OTUD1 noncanonically suppresses Akt activation through its N-terminal intrinsically disordered region. Cell Reports. 42(1). 111916–111916. 13 indexed citations
8.
Wu, Kejia, et al.. (2021). Green tea polyphenols inhibit malignant melanoma progression via regulating circ_MITF/miR‐30e‐3p/HDAC2 axis. Biotechnology and Applied Biochemistry. 69(2). 808–821. 9 indexed citations
9.
Yi, Yuexiong, Yan Fang, Kejia Wu, Yanyan Liu, & Wei Zhang. (2020). Comprehensive gene and pathway analysis of cervical cancer progression. Oncology Letters. 19(4). 3316–3332. 78 indexed citations
10.
Yi, Yuexiong, Yanyan Liu, Wanrong Wu, Kejia Wu, & Wei Zhang. (2019). Reconstruction and analysis of circRNA‑miRNA‑mRNA network in the pathology of cervical cancer. Oncology Reports. 41(4). 2209–2225. 73 indexed citations
12.
Yi, Yuexiong, Yanyan Liu, Wanrong Wu, Kejia Wu, & Wei Zhang. (2018). The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism. Cell Death Discovery. 4(1). 36–36. 17 indexed citations
13.
Wu, Kejia, et al.. (2018). Integration of protein interaction and gene co-expression information for identification of melanoma candidate genes. Melanoma Research. 29(2). 126–133. 5 indexed citations
14.
Wu, Wanrong, et al.. (2018). Lon Peptidase 2, Peroxisomal (LONP2) Contributes to Cervical Carcinogenesis via Oxidative Stress. Medical Science Monitor. 24. 1310–1320. 14 indexed citations
15.
16.
Lv, Qiongying, et al.. (2018). Interleukin‑17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer. International Journal of Oncology. 53(4). 1809–1817. 34 indexed citations
17.
Wu, Kejia, Luyan Tang, Jian Li, et al.. (2017). Modified Technique of Cultured Epithelial Cells Transplantation on Facial Segmental Vitiligo. Journal of Craniofacial Surgery. 28(6). 1462–1467. 7 indexed citations
18.
Wu, Wanrong, et al.. (2017). MiR-203 Participates in Human Placental Angiogenesis by Inhibiting VEGFA and VEGFR2 Expression. Reproductive Sciences. 25(3). 358–365. 12 indexed citations
19.
Wang, Xiwen, Yuexiong Yi, Qiongying Lv, et al.. (2017). Novel 1,3,5‐triazine derivatives exert potent anti‐cervical cancer effects by modulating Bax, Bcl2 and Caspases expression. Chemical Biology & Drug Design. 91(3). 728–734. 10 indexed citations
20.
Yi, Yuexiong, Huirong Li, Qiongying Lv, et al.. (2016). miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1. Oncotarget. 7(44). 72067–72075. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026